About

The Romiplostim Dose Calculator is designed to assist healthcare professionals in determining the appropriate weekly subcutaneous dose of romiplostim for patients with Chronic Immune Thrombocytopenia (ITP). It calculates both the initial starting dose and subsequent dose adjustments based on the patient’s weight and most recent platelet count, following standard clinical guidelines.

Outputs

After you enter the patient data and click “Calculate,” the tool provides the following key outputs:

• Recommended Dose Rate (mcg/kg): This is the prescribed dose in micrograms per kilogram of the patient’s body weight for the upcoming week. The tool adjusts this value based on the platelet count.
• Total Weekly Dose (mcg): The total amount of romiplostim (in micrograms) to be administered, calculated by multiplying the dose rate by the patient’s weight in kilograms.
• Volume for Injection (mL): The final volume to be drawn into the syringe for subcutaneous injection, based on the total dose and the reconstituted drug concentration (typically 500 mcg/mL).

How to use

To ensure accurate calculations, please enter the following information:

1. Patient Weight: Enter the patient’s actual body weight. You can toggle between kilograms (kg) and pounds (lbs). The tool will automatically convert lbs to kg for the calculation.
2. Current Platelet Count: Input the most recent platelet count value (x 10⁹/L). This is the primary factor for dose adjustment.
3. Current or Previous Weekly Dose (mcg/kg): For a new patient, leave this field blank to calculate the standard initial dose of 1 mcg/kg. For an existing patient, enter their current weekly dose rate to calculate the appropriate adjustment.
4. Reconstituted Concentration (mcg/mL): This field defaults to the standard concentration of 500 mcg/mL after reconstitution. Adjust only if using a different concentration.

Dosing overview

Romiplostim dosing is individualized to maintain a platelet count sufficient to prevent clinically significant bleeding (typically ≥50 x 10⁹/L).

Initial Dosing

The recommended starting dose for adults with ITP is 1 mcg/kg of actual body weight, administered as a weekly subcutaneous injection.

Dose Adjustments

The weekly dose is adjusted in increments of 1 mcg/kg based on the platelet response, with the goal of maintaining a target platelet count. The calculator applies the following logic:

• Platelet count < 50 x 10⁹/L: The dose is increased by 1 mcg/kg.
• Platelet count 50-200 x 10⁹/L: The dose is maintained.
• Platelet count > 200 x 10⁹/L (for 2 consecutive weeks): The dose is decreased by 1 mcg/kg. The tool bases this recommendation on a single value, so clinical correlation over time is essential.
• Platelet count > 400 x 10⁹/L: Treatment should be interrupted. Once the count falls below 200 x 10⁹/L, treatment can be restarted at a dose reduced by 1 mcg/kg.

The maximum weekly dose should not exceed 10 mcg/kg. The calculator will automatically cap the recommended dose at this limit.

Switching

When switching a patient to romiplostim from other medical treatments (e.g., corticosteroids, immunoglobulins), it may be necessary to continue the other medications to avoid a rapid drop in platelet count. The decision to taper or discontinue other ITP therapies should be based on clinical judgment and patient response. Always consult the full prescribing information for detailed guidance.

Missed dose

If a weekly dose of romiplostim is missed, the patient should be advised to contact their healthcare provider. The missed dose should be administered as soon as possible, and the regular weekly dosing schedule should be resumed from that day. Two doses should not be administered within the same day.

Safety alerts

The tool includes color-coded alerts to draw attention to important clinical scenarios:

• Red Alert: Indicates a critical situation, such as a platelet count > 400 x 10⁹/L requiring dose interruption or a calculated dose exceeding the 10 mcg/kg maximum.
• Yellow Alert: Signals a need for a dose adjustment (increase or decrease) based on platelet count.
• Blue Alert: Confirms the calculation is for an initial starting dose.

FAQ

What is the initial starting dose of romiplostim calculated by the tool?

If the “Current Dose” field is left blank, the calculator defaults to the standard initial dose of 1 mcg/kg for an adult patient with ITP.

How does the calculator adjust the dose if the platelet count is very high?

If the platelet count is entered as over 400 (x 10⁹/L), the tool will recommend interrupting the dose (a dose of 0 mcg/kg), which is consistent with prescribing guidelines to avoid thrombotic risk.

What is the maximum weekly dose of romiplostim?

The maximum recommended weekly dose is 10 mcg/kg. The calculator will not recommend a dose rate higher than this and will display an alert if the calculated adjustment exceeds this limit.

Can I use pounds (lbs) for patient weight?

Yes, the tool includes a toggle to switch between kilograms (kg) and pounds (lbs). It will automatically perform the necessary conversion for the calculation.

What does “reconstituted concentration” refer to?

This is the concentration of the drug after it has been prepared (reconstituted) for injection. The standard concentration for Nplate® is 500 mcg/mL. The calculator uses this value to determine the final volume to inject.

Why did the calculator recommend decreasing the dose?

A dose decrease of 1 mcg/kg is recommended if the platelet count is above 200 x 10⁹/L. This helps prevent the platelet count from rising to excessively high levels.

Is the calculated volume the final amount I should draw into the syringe?

Yes, the “Volume for Injection” is the final calculated volume in milliliters (mL) that should be administered to the patient for that week’s dose, based on the inputs provided.

How often should the romiplostim dose be evaluated?

Dose adjustments are typically made on a weekly basis after reviewing the latest platelet count. This calculator is intended for use at each of these weekly decision points.

References

1. Nplate® (romiplostim) [Prescribing Information]. U.S. Food and Drug Administration. Available at: FDA.gov.
2. Nplate® (romiplostim): EPAR – Product Information. European Medicines Agency. Available at: EMA.europa.eu.
3. Nplate® (romiplostim) for Healthcare Professionals. Amgen Medical. Available at: AmgenHCP.com.
4. Ghanima W, Cooper N, Rodeghiero F, et al. Romiplostim for the treatment of primary immune thrombocytopenia. Expert Rev Hematol. 2019;12(9):705-720. doi:10.1080/17474086.2019.1643640. Available at: PubMed Central.